Hvis du får Zevalin i 4 måneder eller mindre efter kemoterapi, der omfatter lægemidlet fludarabin, kan du have en større risiko for at udvikle et reduceret antal blodceller.
If you receive Zevalin 4 months or less after another chemotherapy which included the medicine fludarabine, you may have a higher risk to develop a reduced number of blood cells.